Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Wingard

Showing results (141-150 of 267) with videos related to

Pageof 27
Sort By:
Annals of Internal Medicine|January 7, 2015
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trialMichael Boeckh, W Garrett Nichols, Roy F Chemaly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 11, 2015
Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force RecommendationsHarrys A Torres, Pearlie P Chong, Marcos De Lima, et al.
Clinical Transplantation|May 25, 2016
Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experienceLakshmikanth Katragadda, Lindsay M McCullough, Yunfeng Dai, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trialWilliam W Hope, Thomas J Walsh, Joanne Goodwin, et al.
Transplantation and Cellular Therapy|October 12, 2020
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023Nosha Farhadfar, Linda J Burns, Tatenda Mupfudze, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2011
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of AmericaAlison G Freifeld, Eric J Bow, Kent A Sepkowitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2011
Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant ResearchNaynesh R Kamani, Shimareet Kumar, Anna Hassebroek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2002
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II studyBorje S Andersson, Ashwin Kashyap, Victor Gian, et al.
Pageof 27

Showing results (141-150 of 267) with videos related to

Sort By:
Pageof 27
Annals of Internal Medicine|January 7, 2015
Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trialMichael Boeckh, W Garrett Nichols, Roy F Chemaly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 11, 2015
Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force RecommendationsHarrys A Torres, Pearlie P Chong, Marcos De Lima, et al.
Clinical Transplantation|May 25, 2016
Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experienceLakshmikanth Katragadda, Lindsay M McCullough, Yunfeng Dai, et al.
The Journal of Antimicrobial Chemotherapy|April 29, 2016
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trialWilliam W Hope, Thomas J Walsh, Joanne Goodwin, et al.
Transplantation and Cellular Therapy|October 12, 2020
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023Nosha Farhadfar, Linda J Burns, Tatenda Mupfudze, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2011
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of AmericaAlison G Freifeld, Eric J Bow, Kent A Sepkowitz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcomeThomas F Patterson, Helen W Boucher, Raoul Herbrecht, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2011
Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant ResearchNaynesh R Kamani, Shimareet Kumar, Anna Hassebroek, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 21, 2007
Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survivalMary Eapen, Brent R Logan, Dennis L Confer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2002
Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II studyBorje S Andersson, Ashwin Kashyap, Victor Gian, et al.
Pageof 27